Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy

International Journal of Radiation Biology

Volumn 90, Issue 4, 2014, Pages 284-290

  Salata, Camila ^a   Ferreira Machado, Samara Cristina ^a,b   De Andrade, Cherley Borba Vieira ^a,c   Mencalha, André Luiz ^a   Mandarim De Lacerda, Carlos Alberto ^a   De Almeida, Carlos Eduardo ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Lab de Biologia Celular e Tecidual   (Brazil)

Author keywords

Apoptosis; Breast cancer; Chemo radiotherapy; Fibrosis; Heart

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; MESSENGER RNA; PROCOLLAGEN; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

ADJUVANT CHEMOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; COMBINATION CHEMOTHERAPY; CONNECTIVE TISSUE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; IRRADIATION; LEUKOCYTE COUNT; LEUKOPENIA; MICROSCOPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; MYOCYTES, CARDIAC; NEOADJUVANT THERAPY; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR FUNCTION, LEFT;

EID: 84897481078     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2014.887869     Document Type: Article

References (46)

1. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. 2010. Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 102:14-25.
2. Bezerra DG, Lacerda Andrade LM, Pinto da Cruz FO, Mandarim-de-Lacerda CA. 2008. Atorvastatin attenuates cardiomyocyte loss in adult rats from protein-restricted dams. J Card Fail 14:151-160.
3. Bird BRJH, Swain SM. 2008. Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems. Clin Cancer Res 14: 14-24.
4. Boerma M, Hauer-Jensen M. 2011. Preclinical research into basic mechanisms of radiation-induced heart disease. Cardiol Res Pract 2011:1-8.
5. Boerma M, Wang J, Sridharan V, Herbert JM, Hauer-Jensen M. 2013. Pharmacological induction of transforming growth factor-beta1 in rat models enhances radiation injury in the intestine and the heart. PLoS One 8:e70479.
6. Carneseca EC, Mauad EC, Araujo MA, Dalbo RM, Longatto Filho A, Vazquez Vde L. 2013. The Hospital de Cancer de Barretos Registry: An analysis of cancer survival at a single institution in Brazil over a 10-year period. BMC Res Notes 6:141.
7. Casini S, Tan HL, Demirayak I, Remme CA, Amin AS, Scicluna BP, Chatyan H, Ruijter JM, Bezzina CR, van Ginneken AC, et al. 2010. Tubulin polymerization modifies cardiac sodium channel expression and gating. Cardiovasc Res 85:691-700.
8. Chargari C, Kirov KM, Bollet MA, Magne N, Vedrine L, Cremades S, Beuzeboc P, Fourquet A, Kirova YM. 2011. Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment. Cancer Treat Rev 37: 321-330.
9. Charniot JC, Zerhouni K, Kidouche R, Nascimbeni L, Gandjbakhch I, Artigou JY. 2006. Late cardiac complications of radiation therapy. Presse Med 35:239-242 [in French].
10. Colleoni M, Orlando L, Sanna G, Rocca A, Maisonneuve P, Peruzzotti G, Ghisini R, Sandri MT, Zorzino L, Nole F, et al. 2006. Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: Antitumor activity and biological efects. Ann Oncol 17:232-238.
11. de Almeida CE, Fournier-Bidoz N, Massabeau C, Mazal A, Canary PC, Kuroki IR, Campana F, Fourquet A, Kirova YM. 2012. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy ofileft breast and internal mammary nodes. Cancer/ Radiothérapie 16:44-51.
12. Ferreira-Machado SC, Salata C, Rocha NN, Correa AF, Corte-Real S, Peregrino AA, de Campos VM, Andrade CB, Bernardo-Filho M, Cabral-Neto JB, et al. 2013. Caspase-3 activation and increased procollagen type I in irradiated hearts. An Acad Bras Cienc 85: 215-222.
13. Ferreira-Machado SC, Rocha NN, Mencalha AL, De Melo LD, Salata C, Ribeiro AF, Torres Tda S, Mandarim-De-Lacerda CA, Canary PC, Peregrino AA, et al. 2010. Up-regulation of angiotensin-converting enzyme and angiotensin II type 1 receptor in irradiated rats. Int J Radiat Biol 86: 880-887.
14. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
15. Gaya AM, Ashford RF. 2005. Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 17:153-159.
16. Grant DS, Williams TL, Zahaczewsky M, Dicker AP. 2003. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J Cancer 104:121-129.
17. Gundersen HJG. 1977. Notes on the estimation of the numerical density of arbitrary profiles: The edge efect. JMicrosc 111:219-227.
18. Jelonek K, Walaszczyk A, Gabrys D, Pietrowska M, Kanthou C, Widlak P. 2011. Cardiac endothelial cells isolated from mouse heart-a novel model for radiobiology. Acta Biochim Pol 58:397-404.
19. Kirova YM, de Almeida CE, Canary PC, Kuroki Y, Massabeau C, Fournier-Bidoz N. 2011. Heart, coronaries and breast cancer radiotherapy. Breast 20:196-197.
20. Kruse JJ, Zurcher C, Strootman EG, Bart CI, Schlagwein N, Leer JW, Wondergem J. 2001. Structural changes in the auricles of the rat heart after local ionizing irradiation. Radiother Oncol 58:303-311.
21. Kunapuli S, Rosanio S, Schwarz ER. 2006. 'How do cardiomyocytes die? ' apoptosis and autophagic cell death in cardiac myocytes. J Card Fail 12:381-391.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al. 2006. Recommendations for chamber quantification. Eur J Echocardiogr 7:79-108.
23. Lenihan DJ, Esteva FJ. 2008. Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer. Oncologist 13:1224-1234.
24. Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG. 1997. Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874-881.
25. Mandarim-de-Lacerda CA, Fernandes-Santos C, Aguila MB. 2010. Image analysis and quantitative morphology. Methods Mol Biol 611:211-225.
26. Maxwell Parkin LMGF. 2006. Use of statistics to assess the global burden of breast cancer. Breast J 12: 10.
27. Rapoport BL, Demetriou GS, Moodley SD, Benn CA. 2013. When and how do I use neoadjuvant chemotherapy for breast cancer? Curr Treat Options Oncol. doi:10.1007/s11864-013-0266-0.
28. Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. FASEB J 22:659-661.
29. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schluter KD, Bohm M. 2002. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 283:H1253-1262.
30. Salata C, Ferreira-Machado SC, Mencalha AL, de Andrade CB, de Campos VM, Mandarim-de-Lacerda CA, Dealmeida CE. 2012. Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin-angiotensin system related genes in cardiac tissue. J Renin Angiotensin Aldosterone Syst 14:330-336.
31. Schimmel KJM, Richel DJ, van den Brink RBA, Guchelaar H-J. 2004. Cardiotoxicity of cytotoxic drugs. Cancer Treatm Rev 30:181-191.
32. Schultz-Hector S, Sund M, Tames HD. 1992. Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol 23: 33-40.
33. Siegel R, Naishadham D, Jemal A. 2013. Cancer statistics, 2013. CA: Cancer J Clin 63:11-30.
34. Sweeney CJ, MillerKD, Sissons SE, NozakiS, HeilmanDK, ShenJ, Sledge GW Jr. 2001. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res 61: 3369-3372.
35. Taylor CW, McGale P, Povall JM, Tomas E, Kumar S, Dodwell D, Darby SC. 2009. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. Int J Radiat Oncol Biol Phys 73: 1061-1068.
36. To H, Shin M, Tabuchi M, Sakaguchi H, Takeuchi A, Matsunaga N, Higuchi S, Ohdo S. 2004. Influence of dosing schedule on toxicity and antitumor effects of a combination of adriamycin and docetaxel in mice. Clin Cancer Res 10:8.
37. Tokatli F, Uzal C, Doganay L, Kocak Z, Kaya M, Ture M, Kurum T, Alkaya F, Karadag H, Kutlu K. 2004. The potential cardioprotective effects of amifostine in irradiated rats. Int J Radiat Oncol Biol Phys 58: 1228-1234.
38. Tschanz SA, Burri PH, Weibel ER. 2011. A simple tool for stereological assessment of digital images: the STEPanizer. J Microsc 243:47-59.
39. Vennarini S, Fournier-Bidoz N, Aristei C, de Almeida CE, Servois V, Campana F, Mosseri V, Fourquet A, Kirova YM. 2013. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. Br J Radiol 86:20120643.
40. Wang J, Boerma M, Fu Q, Hauer-Jensen M. 2007. Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 13:3047-3055.
41. Wang Y, Liu X, Zhang D, Chen J, Liu S, Berk M. 2013. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. BMC Med 11: 32.
42. Wynn TA. 2008. Cellular and molecular mechanisms of fbrosis. J Pathol 214:199-210.
43. Yarnold J, Vozenin Brotons M-C. 2010. Pathogenetic mechanisms in radiation flbrosis. Radiother Oncol 97: 149-161.
44. Yarnold J, Brotons MC. 2010. Pathogenetic mechanisms in radiation flbrosis. Radiother O ncol 97: 149-161.
45. Yeh ETH, Bickford CL. 2009. Cardiovascular complications of cancer therapy. J Am Coll Cardiol 53:2231-2247.
46. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG. 1982. Use ofltibial length to quantify cardiac hypertrophy: Application in the aging rat. Am J Physiol 243:H941-947.